Financière de Tubize SA (ENXTBR: TUB)
Health Care · Pharmaceuticals · BE
€170.00
+0.41% today · -29.0% 1Y
Financière de Tubize SA (ENXTBR: TUB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $8.47B and employs 3 people.
Over the last twelve months the share price has lost 29.0%, trading between 168.10 and 250.50.
Tweenvest scores Financière de Tubize SA across four factors: quality 54/100, growth 22/100, dividend 68/100. Its strongest factor is dividend.
TUB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.47B
- Revenue (TTM)
- —
- P/E
- 76.89
- EPS
- 2.21
- Dividend yield
- 0.64%
- Beta (5Y)
- 0.40
- 52-week high
- €250.50
- 52-week low
- €168.10
- Avg volume (3M)
- —
- Shares outstanding
- 44.51M
- Employees
- 3
- Next earnings
- —
About Financière de Tubize SA
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.
- ISIN
- BE0003823409
- Founded
- 1928
- Listed since
- Jan 4, 2000
- Exchange
- Euronext Brussels
- Currency
- EUR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lupin LimitedBSE: 500257 | $9.26B | Rs1,960.00 | -3.40% |
| Axsome Therapeutics, Inc.NasdaqGM: AXSM | $8.82B | $167.95 | -0.24% |
| Krka, d. d.LJSE: KRKG | $8.76B | €258.50 | +0.78% |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd.SHSE: 600196 | $8.72B | CN¥23.89 | -0.54% |
| Eisai Co., Ltd.TSE: 4523 | $8.19B | ¥4,603.00 | -0.60% |
| ALK-Abelló A/SCPSE: ALK B | $7.56B | Dkr228.00 | +0.26% |
| Kyowa Kirin Co., Ltd.TSE: 4151 | $7.35B | ¥2,222.50 | +0.61% |
| Amneal Pharmaceuticals, Inc.NasdaqGS: AMRX | $6.93B | $20.00 | +0.43% |
Figures last refreshed Oct 11, 2026.